NEW YORK (GenomeWeb) – Preconception genetic testing firm GenePeeks said today that it has signed a distribution agreement with the Alliance Global Group (AGBL), which is based in Dubai in the United Arab Emirates.

Under the agreement, AGBL will offer GenePeeks' Preconception Screen to patients, healthcare providers, and laboratories in the Middle East and in Africa. AGBL will also introduce additional applications of GenePeeks' technology, which is called Virtual Progeny Analytics, through partnerships with centers of excellence in the region.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.